International Internal Medicine Journal(IIMJ)

Creighton University School of Health Science, Department of Internal Medicine, AZ, USA

Publications

• Research Article   
  Insights into Readmission Trends Following Inpatient Chemotherapy for Acute Lymphoblastic Leukemia: A 30-Day Analysis
  Author(s): Silpa Choday*, Diana Zamora, Anthony Yeung and Miguel Gonzalez
  
  Introduction: Acute lymphoblastic leukemia (ALL) has significant morbidity due to its aggressive course and intensive treatment protocols. Understanding the patterns of readmission after inpatient chemotherapy is crucial for optimizing patient care and resource allocation. Methods: We conducted a retrospective analysis of the National Readmission Database among ALL patients who underwent inpatient chemotherapy between 2016 and 2020. We examined trends in 30-day readmission rates, factors associated with readmission, and outcomes such as remission and relapse. Results: A total of 22,483 admissions were analyzed. Of these, 72.5% (16,294) experienced readmission. Notably, the trend in readmission rates declined between 2016 to 2020, dropping from 76.1% to 66.3%. Among the 16,294 readmissions, 3,607 achieved remissions.. Read More»
  

  Abstract HTML PDF